U.S., Oct. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07216352) titled 'Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging' on Oct. 08.
Brief Summary: The primary objective is to evaluate the safety and efficacy of a topical serum (AGE serum) in improving visible signs of aging (e.g., fine lines, wrinkles, sagging, texture, radiance) on the full face and neck.The study will be conducted in non-menopausal female and male subjects who are on glucagon-like peptide-1 (GLP-1) agonist therapy for weight loss.
Study Start Date: Oct. 25
Study Type: INTERVENTIONAL
Condition:
Laxity; Skin
Intervention:
OTHER: AGE Serum
AGE serum is a topical that contains a ...